Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study
Phase: PHASE2 | Sponsor: University of British Columbia | Compound: Psilocybin
- Status
- recruiting
- Institution
- University of British Columbia
- Start date
- 2025-10-27
- End date
- 2026-08-31
- Registry ID
- NCT05585229
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.